ask="19.50"
ask_size="100"
average_daily_volume="39131"
bid="N/A"
bid_size="N/A"
book_value="5.83"
change="-1.03"
change_from_200_day_moving_average="-3.30"
change_from_50_day_moving_average="-3.66"
change_from_52_week_high="-10.47"
change_From_52_week_low="5.87"
change_in_percent="-6.09%"
close="15.89"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.23"
ex_dividend_date="N/A"
float_shares="6895000"
high="17.10"
high_52_weeks="26.36"
last_trade_date="2/9/2017"
last_trade_price="15.89"
last_trade_size="1225"
last_trade_time="4:00pm"
low="15.65"
low_52_weeks="10.02"
market_capitalization="265.59M"
moving_average_200_day="19.19"
moving_average_50_day="19.55"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="16.51"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-17.19%"
percent_change_from_50_day_moving_average="-18.74%"
percent_change_from_52_week_high="-39.72%"
percent_change_from_52_week_low="+58.58%"
previous_close="16.92"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.90"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="4.14"
stock_exchange="NGM"
symbol="PTGX"
volume="33350"
weeks_range_52="10.02 - 26.36"
